SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018579
Filing Date
2024-05-10
Accepted
2024-05-10 09:20:31
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 617299
2 ex31-1.htm EX-31.1 19997
3 ex31-2.htm EX-31.2 18770
4 ex32-1.htm EX-32.1 8361
  Complete submission text file 0001493152-24-018579.txt   3522736

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20240331.xsd EX-101.SCH 33593
6 XBRL CALCULATION FILE pulm-20240331_cal.xml EX-101.CAL 49835
7 XBRL DEFINITION FILE pulm-20240331_def.xml EX-101.DEF 105215
8 XBRL LABEL FILE pulm-20240331_lab.xml EX-101.LAB 260558
9 XBRL PRESENTATION FILE pulm-20240331_pre.xml EX-101.PRE 194444
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 422705
Mailing Address 36 CROSBY DRIVE SUITE 100 BEDFORD MA 01730
Business Address 36 CROSBY DRIVE SUITE 100 BEDFORD MA 01730 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 24933093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)